Smoking, variation in N-acetyltransferase 1 (NAT1) and 2 (NAT2), and risk of non-Hodgkin lymphoma: a pooled analysis within the InterLymph consortium
Year: 2012
Type: article
Source: Cancer Causes & Control
Authors: Todd M. Gibson, Karin E. Smedby, Christine F. Skibola, David W. Hein, Susan L. Slager, Silvia de Sanjosé, Claire M. Vajdic, Yawei Zhang, Brian C.-H. Chiu, Sophia S. Wang, Henrik Hjalgrim, Alexandra Nieters, Paige M. Bracci, Anne Kricker, Tongzhang Zheng, Carol Kolar, James R. Cerhan, Hatef Darabi, Nikolaus Becker, Lucia Conde, Theodore R. Holford, Dennis D. Weisenburger, Anneclaire J. De Roos, Katja Butterbach, Jacques Riby, Wendy Cozen, Yolanda Benavente, Casey Palmers, Elizabeth A. Holly, Joshua N. Sampson, Nathaniel Rothman, Bruce K. Armstrong, Lindsay M. Morton
Institutions: National Cancer Institute, Division of Cancer Epidemiology and Genetics, Karolinska Institutet, University of California, Berkeley, University of Louisville, Mayo Clinic, Institut d'Investigació Biomédica de Bellvitge, Institut Català d'Oncologia, Centro de Investigación Biomédica en Red de Epidemiología y Salud Pública, UNSW Sydney, Yale University, University of Chicago, City Of Hope National Medical Center, City of Hope, Beckman Research Institute, Statens Serum Institut, University of Freiburg, University Medical Center Freiburg, University of California, San Francisco, The University of Sydney, University of Nebraska Medical Center, German Cancer Research Center, University of Washington, Fred Hutch Cancer Center, University of Southern California, USC Norris Comprehensive Cancer Center
Language: English
Subfield: Pharmacology
Domain: Life Sciences
Open Access status: green
OpenAlex ID: W2091449686